Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004423399 | SCV004912404 | uncertain significance | not specified | 2024-01-02 | criteria provided, single submitter | clinical testing | The c.2270A>G (p.E757G) alteration is located in exon 19 (coding exon 19) of the AXL gene. This alteration results from a A to G substitution at nucleotide position 2270, causing the glutamic acid (E) at amino acid position 757 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |